Radiation Therapy: Clinical Trials

7 trials for Radiation Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 unknown, 1 active not recruiting, 1 completed. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Recruiting 2, Unknown 2, Active not recruiting 1, Completed 1, Suspended 1
Phase 21Unknown 1

Follow Radiation Therapy: new trials by email Literature Review of Radiation Therapy trials Research Report on Radiation Therapy

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)
Second-Line Chemotherapy, Radiation Therapy, Cadonilimab (AK104) - Colon Rectal Cancer Adenocarcinoma, Peritoneal (Metastatic) Cancer
Phase 3RecruitingFudan University1982026-10-012026-10-13
SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy
SBRT or RT on primary pancreatic and/or metastatic distant lesions before chemotherapy, Standard systemic therapy (chemotherapy) without RT/SBRT - Radiation Therapy, SBRT
Phase 3Active not recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1082025-01-102025-04-27
18F-FLUC PET/MR in Patients With Brain Mets
F-Fluciclovine radiotracer - Brain Metastasis, Radiation Therapy
Phase 3RecruitingUniversity of Wisconsin, Madison302024-01-102026-06-22
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
Questionnaires, Early Radiation Oncology Involvement Alongside Standard Oncologic Care - Radiation Therapy, Metastatic Cancer
Phase 3SuspendedRutgers, The State University of New Jersey1562023-07-132026-01-07
Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy
Toripalimab, Tegafur, IMRT - Esophageal Cancer, Radiation Therapy
Phase 2 / Phase 3UnknownTaizhou Hospital602022-07-012023-04-18
Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients
first line systemic therapy, 3D radiotherapy or IMRT - Non-Small Cell Carcinoma of Lung, TNM Stage 4, Radiation Therapy
Phase 3CompletedMenoufia University752020-09-252024-09-19
A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer
Radiation Method B, Cisplatin, Radiation Method A - Cervical Cancer, Lymphocyst
Phase 3UnknownSun Yat-sen University5402017-06-012017-07-14

Narrower conditions

Neoplasm Metastasis (2)  ·  Brain Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Lymphocele (1)  ·  Motor Activity (1)  ·  Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Site (4)  ·  Neoplastic Processes (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Cysts (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Esophageal Diseases (1)

Interventions

Radiotherapy (2)  ·  Cisplatin (1)  ·  Drug Therapy (1)  ·  Radiation (1)  ·  Radiosurgery (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  S 1 (combination) (1)  ·  Surveys and Questionnaires (1)  ·  Tegafur (1)  ·  toripalimab (1)

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Fudan University (1)  ·  Menoufia University (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Sun Yat-sen University (1)  ·  Taizhou Hospital (1)  ·  University of Wisconsin, Madison (1)

Countries

China (3)  ·  United States (2)  ·  Egypt (1)  ·  Italy (1)

Top investigators

Ahmed Sohaib, MD (1)  ·  Eman AR Tawfeek, MD (1)  ·  Enas AB Elkhouly, MD (1)  ·  Malcolm Mattes, MD (1)  ·  Michael Veronesi, MD, PhD (1)  ·  Reham A Abdel Aziz, MD (1)  ·  Wei-jun Ye, M.D (1)  ·  Yostena Mekhail, M.Sc (1)